Prognostic factors for the development of acneiform eruptions in patients on epidermal growth factor receptor inhibitors

J Am Acad Dermatol. 2023 Apr;88(4):869-870. doi: 10.1016/j.jaad.2022.10.005. Epub 2022 Oct 10.
No abstract available

MeSH terms

  • Acneiform Eruptions* / chemically induced
  • Acneiform Eruptions* / drug therapy
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents* / therapeutic use
  • Cetuximab / therapeutic use
  • ErbB Receptors
  • Humans
  • Prognosis

Substances

  • Antibodies, Monoclonal
  • ErbB Receptors
  • Antineoplastic Agents
  • Cetuximab